Stockscreener 앱 받기
76.56
0.46%
-0.35
시장 영업 전:
76.34
-0.22
-0.29%
전일 마감가:
$76.91
열려 있는:
$77.4
하루 거래량:
7.54M
Relative Volume:
1.07
시가총액:
$32.10B
수익:
$9.51B
순이익/손실:
$2.64B
주가수익비율:
12.68
EPS:
6.0361
순현금흐름:
$2.14B
1주 성능:
+1.32%
1개월 성능:
-0.91%
6개월 성능:
-38.58%
1년 성능:
-48.97%
1일 변동 폭
$75.68
$78.05
1주일 범위
$73.38
$78.05
52주 변동 폭
$71.47
$160.48
조에티스 Stock (ZTS) Company Profile
명칭
Zoetis Inc
전화
973-822-7000
주소
10 SYLVAN WAY, PARSIPPANY, NJ
Compare ZTS vs TAK, HLN, TEVA, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ZTS
Zoetis Inc
|
76.56 | 32.24B | 9.51B | 2.64B | 2.14B | 6.0361 |
TAK
Takeda Pharmaceutical Co Adr
|
17.15 | 53.43B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
10.10 | 44.52B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.03 | 37.52B | 17.53B | 1.58B | 444.18M | 1.3457 |
UTHR
United Therapeutics Corp
|
535.67 | 22.46B | 3.17B | 1.29B | 1.01B | 27.09 |
조에티스 Stock (ZTS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-15 | 개시 | Citigroup | Buy |
| 2026-01-22 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2025-12-15 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2025-12-09 | 개시 | Barclays | Equal Weight |
| 2025-11-21 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2025-07-17 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2025-06-18 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-12-02 | 개시 | Leerink Partners | Outperform |
| 2024-07-25 | 개시 | BTIG Research | Buy |
| 2024-01-12 | 재확인 | Stifel | Buy |
| 2023-12-19 | 재개 | Jefferies | Buy |
| 2023-12-07 | 개시 | Exane BNP Paribas | Outperform |
| 2023-09-06 | 개시 | HSBC Securities | Buy |
| 2022-07-12 | 개시 | Piper Sandler | Overweight |
| 2021-11-18 | 개시 | Morgan Stanley | Overweight |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-07-16 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2021-03-08 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2021-03-08 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-09-21 | 개시 | Atlantic Equities | Overweight |
| 2020-08-14 | 업그레이드 | Edward Jones | Hold → Buy |
| 2020-08-12 | 다운그레이드 | Gabelli & Co | Buy → Hold |
| 2020-05-27 | 개시 | Jefferies | Buy |
| 2020-01-10 | 개시 | Raymond James | Mkt Perform |
| 2019-09-09 | 개시 | Goldman | Buy |
| 2019-07-01 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-06-11 | 개시 | Barclays | Overweight |
| 2019-05-23 | 개시 | Guggenheim | Buy |
| 2019-05-03 | 다운그레이드 | Gabelli & Co | Buy → Hold |
| 2019-03-20 | 개시 | SunTrust | Hold |
| 2019-03-04 | 업그레이드 | Stifel | Hold → Buy |
| 2019-01-23 | 개시 | UBS | Neutral |
| 2018-10-15 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-08-22 | 다운그레이드 | Stifel | Buy → Hold |
| 2018-08-03 | 재확인 | Stifel | Buy |
| 2018-04-19 | 재확인 | Citigroup | Buy |
| 2018-03-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2018-02-16 | 재확인 | Stifel | Buy |
| 2018-01-04 | 업그레이드 | Citigroup | Neutral → Buy |
모두보기
조에티스 주식(ZTS)의 최신 뉴스
Assetmark Inc. Increases Stake in Zoetis Inc. $ZTS - MarketBeat
ZTS Investors Have Opportunity to Lead Zoetis Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
Price to book forward of Zoetis, Inc. Class A – MIL:1ZTS - TradingView
ZOETIS DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Zoetis Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ZTS - GlobeNewswire Inc.
ZTS Investors Have Opportunity to Lead Zoetis Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
Zoetis Inc. $ZTS Stock Holdings Trimmed by Tandem Investment Advisors Inc. - MarketBeat
Mediolanum International Funds Ltd Buys 14,539 Shares of Zoetis Inc. $ZTS - MarketBeat
Wealthfront Advisers LLC Increases Stake in Zoetis Inc. $ZTS - MarketBeat
Hsbc Holdings PLC Raises Stock Holdings in Zoetis Inc. $ZTS - MarketBeat
Kestra Advisory Services LLC Decreases Stock Holdings in Zoetis Inc. $ZTS - MarketBeat
California Public Employees Retirement System Sells 97,206 Shares of Zoetis Inc. $ZTS - MarketBeat
Zoetis Inc. (ZTS) Investors: July 27, 2026, Filing Deadline - GlobeNewswire
How New OA Drug and Vaccine Approvals Amid Lawsuits At Zoetis (ZTS) Has Changed Its Investment Story - simplywall.st
Bartlett & CO. Wealth Management LLC Decreases Position in Zoetis Inc. $ZTS - MarketBeat
Clifford Swan Investment Counsel LLC Grows Holdings in Zoetis Inc. $ZTS - MarketBeat
Zoetis Inc. (NYSE:ZTS) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Zoetis, Neogen deal draws antitrust concerns in Australia - Seeking Alpha
Zoetis' Acquisition of Neogen Genomics Business Faces Regulatory Scrutiny in Australia - Benzinga
Zoetis (ZTS) Lenivia Launch Puts Valuation Back In Focus - simplywall.st
Zoetis: An Attractive Risk-Reward Opportunity - Seeking Alpha
Australia's ACCC Says Zoetis' Acquisition Of Neogen Genomics Requires Phase 2 Review - TradingView
Zoetis (NYSE:ZTS) Stock Acquired Rep. Byron Donalds - MarketBeat
Principal Financial Group Inc. Has $65.29 Million Stock Holdings in Zoetis Inc. $ZTS - MarketBeat
Bleakley Financial Group LLC Acquires New Position in Zoetis Inc. $ZTS - MarketBeat
Aware Super Pty Ltd as trustee of Aware Super Acquires Shares of 250,920 Zoetis Inc. $ZTS - MarketBeat
Bank of New York Mellon Corp Reduces Stake in Zoetis Inc. $ZTS - MarketBeat
Zoetis-Neogen Genomics deal referred to in-depth review in Australia - MLex
Daily Brief Health Care: First Wave BioPharma , NeuroSpectrum Insights, Mesoblast Ltd, Know Labs , Zoetis Inc, CTT Pharmaceutical Holdings, Oncolytics Biotech, ATAI Life Sciences NV and more - Smartkarma
Zoetis Inc (ZTS) Stock Up 3.2% and Still Undervalued -- GF Score: 76/100 - GuruFocus
Zoetis Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Zoetis Inc. (ZTS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
ZOETIS DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, - GlobeNewswire
Byron Donalds of Florida’s 19th District adjusts portfolio, trading in Cadence, Monolithic and Zoetis stocks - Investing.com
Zoetis Gains as VitalRADS Deal Boosts Diagnostics Narrative - Quiver Quantitative
Bronstein, Gewirtz & Grossman LLC Urges Zoetis Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire
SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of July 27, 2026 in Zoetis Inc. LawsuitZTS - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Zoetis Inc. of Class Action Lawsuit and Upcoming DeadlinesZTS - PR Newswire
ZOETIS INC. (ZTS) SHAREHOLDER ALERT Bernstein Liebhard LLP - GlobeNewswire
Zoetis to acquire VitalRADS to expand veterinary diagnostics platform - ROI-NJ
Zoetis Earnings Preview: What to Expect - Barchart.com
ZTS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Zoetis Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Zoetis to acquire vet teleradiology services firm VitalRads - pehub.com
Zoetis Deadline: ZTS Investors Have Opportunity to Lead Zoetis Inc. Securities Fraud Lawsuit - Pasco News
Kaplan Fox & Kilsheimer LLP Alerts Zoetis Inc. (NYSE: ZTS) Investors to a Securities Class Action Deadline on July 27, 2026 - NewMediaWire
Kaplan Fox & Kilsheimer LLP Alerts Zoetis Inc. (NYSE: ZTS) Invest - The National Law Review
Zoetis Inc. (ZTS) Investors Have Opportunity to Lead Securities Fraud Class Action LawsuitContact KTMC - The Malaysian Reserve
Here's What We Like About Zoetis' (NYSE:ZTS) Upcoming Dividend - simplywall.st
Levi & Korsinsky Reminds Zoetis Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of July 27, 2026ZTS - PR Newswire
Zoetis launches Lenivia for dog osteoarthritis pain in Canada, EU - Investing.com
Zoetis Launches Lenivia for Osteoarthritis Pain Management (ZTS) - GuruFocus
Zoetis Launches Lenivia® (izenivetmab injection) in Canada and the European Union - Business Wire
조에티스 (ZTS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
조에티스 주식 (ZTS) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Bisaro Paul | Director |
May 13 '26 |
Buy |
75.88 |
2,000 |
151,750 |
27,862 |
| MCCALLISTER MICHAEL B | Director |
May 11 '26 |
Buy |
77.76 |
3,000 |
233,273 |
24,524 |
| PECK KRISTIN C | Chief Executive Officer |
Feb 17 '26 |
Option Exercise |
41.83 |
20,000 |
836,600 |
121,337 |
| PECK KRISTIN C | Chief Executive Officer |
Feb 17 '26 |
Sale |
127.05 |
20,000 |
2,540,964 |
101,337 |
0.59%
1.25%
자본화:
|
볼륨(24시간):